Nephrology Medical News about Diabetes Insipidus

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09

Bockenhauer D et al. – The V88M mutation is associated with phenotypical diversity, which may be explained by the fact that both the expression level and the hormone–binding affinity are affected by the mutation. The results provide a rational basis for treatment trials with vasopressin analogues in combination with pharmacologic chaperones in patients with this recurrently identified mutation.

<< Previous
The Science of Stewardship: Due Diligence for Kidney Donors and...

Next >>
Outcome definitions in non-dialysis intervention and prevention...